PL351323A1 - Inhibitors of lfa−1 binding to icams and uses thereof - Google Patents
Inhibitors of lfa−1 binding to icams and uses thereofInfo
- Publication number
- PL351323A1 PL351323A1 PL00351323A PL35132300A PL351323A1 PL 351323 A1 PL351323 A1 PL 351323A1 PL 00351323 A PL00351323 A PL 00351323A PL 35132300 A PL35132300 A PL 35132300A PL 351323 A1 PL351323 A1 PL 351323A1
- Authority
- PL
- Poland
- Prior art keywords
- icams
- lfa
- inhibitors
- binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/01—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton
- C07C323/09—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton having sulfur atoms of thio groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/33—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring
- C07C323/35—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring the thio group being a sulfide group
- C07C323/37—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring the thio group being a sulfide group the sulfur atom of the sulfide group being further bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/70—Sulfur atoms
- C07D277/74—Sulfur atoms substituted by carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/90—Benzo [c] furans; Hydrogenated benzo [c] furans with an oxygen atom in position 1 and a nitrogen atom in position 3, or vice versa
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Control Of El Displays (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28532599A | 1999-04-02 | 1999-04-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL351323A1 true PL351323A1 (en) | 2003-04-07 |
Family
ID=23093752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL00351323A PL351323A1 (en) | 1999-04-02 | 2000-04-03 | Inhibitors of lfa−1 binding to icams and uses thereof |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1165504A2 (en) |
JP (1) | JP2002541141A (en) |
KR (1) | KR20020003559A (en) |
CN (2) | CN1721401A (en) |
AU (2) | AU774054B2 (en) |
BG (1) | BG106019A (en) |
BR (1) | BR0009421A (en) |
CA (1) | CA2369005A1 (en) |
CZ (1) | CZ20013524A3 (en) |
EA (1) | EA200101017A1 (en) |
EE (1) | EE200100514A (en) |
HR (1) | HRP20010777A2 (en) |
HU (1) | HUP0201904A3 (en) |
IL (1) | IL145528A0 (en) |
IS (1) | IS6096A (en) |
MX (1) | MXPA01009915A (en) |
NO (1) | NO20014768L (en) |
NZ (1) | NZ515238A (en) |
PL (1) | PL351323A1 (en) |
SK (1) | SK14022001A3 (en) |
WO (1) | WO2000059878A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6515124B2 (en) * | 2000-02-09 | 2003-02-04 | Hoffman-La Roche Inc. | Dehydroamino acids |
WO2002002539A1 (en) | 2000-06-29 | 2002-01-10 | Abbott Laboratories | Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
US7064180B2 (en) | 2000-07-31 | 2006-06-20 | The General Hospital Corporation | High affinity integrin polypeptides and uses thereof |
US7323552B2 (en) | 2000-07-31 | 2008-01-29 | The General Hospital Corporation | Variant integrin polypeptides and uses thereof |
US7153944B2 (en) * | 2000-07-31 | 2006-12-26 | The General Hospital Corporation | High affinity integrin polypeptides and uses thereof |
JP2004504827A (en) * | 2000-07-31 | 2004-02-19 | ザ ジェネラル ホスピタル コーポレーション | High affinity integrin polypeptides and methods of use |
UA81749C2 (en) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Derivated of phenylpiperazine as serotonin reuptake inhibitorS |
JP4617449B2 (en) | 2002-07-11 | 2011-01-26 | ヴィキュロン ファーマシューティカルズ インコーポレイテッド | N-hydroxyamide derivative having antibacterial activity |
SI1626720T1 (en) | 2003-04-04 | 2008-12-31 | Lundbeck & Co As H | 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors |
BRPI0417858B1 (en) | 2003-12-23 | 2017-10-10 | H. Lundbeck A/S | DERIVATIVE COMPOUNDS OF ANILINE AND PHARMACEUTICAL COMPOSITION THAT UNDERSTAND IT |
WO2005092836A1 (en) * | 2004-03-15 | 2005-10-06 | Eli Lilly And Company | Opioid receptor antagonists |
AR052308A1 (en) | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | DERIVATIVES OF 2- (1H-INDOLILSULFANIL) -ARILAMINE AND A PHARMACEUTICAL COMPOSITION CONTAINING THE COMPOUND |
US7629473B2 (en) | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
AR054393A1 (en) | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | DERIVATIVES OF BENZO (B) FURANO AND BENZO (B) THIOPHEN, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES MEDIATED BY THE INHIBITION OF THE REINFORCEMENT OF AMINA BOSS NEUTRANTS. |
JP2007008877A (en) * | 2005-06-30 | 2007-01-18 | Sato Pharmaceutical Co Ltd | Pharmaceutical composition with 2-pyridone derivative as active ingredient |
CA2622545A1 (en) * | 2005-10-18 | 2007-04-26 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A | Naphthyl derivatives as inhibitors of beta-amyloid aggregation |
US8436025B2 (en) * | 2008-09-19 | 2013-05-07 | CompleGen Partners, Inc. | Compounds and methods for PKC theta inhibition |
US9884046B1 (en) * | 2017-06-26 | 2018-02-06 | Macau University Of Science And Technology | Method of treating lung cancer |
NL2026714B1 (en) | 2020-10-20 | 2022-06-16 | Lumicks Ca Holding B V | Improved detection of lymphocyte - target cell interaction |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1493728A1 (en) * | 1965-07-20 | 1969-08-28 | Lauterbach Dr Rudolf | Process for the preparation of aminophenylthioethers |
US3576872A (en) * | 1968-05-03 | 1971-04-27 | Exxon Research Engineering Co | Herbicidal s-aryl arylamides |
DE2313721A1 (en) * | 1973-03-20 | 1974-10-03 | Bayer Ag | NEW 1-PHENYL-SUBSTITUTED 1,3,5TRIAZINE, THE METHOD FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT |
GR73690B (en) * | 1979-01-15 | 1984-04-02 | Celamerck Gmbh & Co Kg | |
US4973599A (en) * | 1989-03-14 | 1990-11-27 | Hoffman-La Roche Inc. | Phenylthioheterocyclic derivatives |
GB9403408D0 (en) * | 1994-02-23 | 1994-04-13 | Wellcome Found | Therapeutic benzonitriles |
TW574214B (en) | 1994-06-08 | 2004-02-01 | Pfizer | Corticotropin releasing factor antagonists |
US6110922A (en) * | 1998-12-29 | 2000-08-29 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
-
2000
- 2000-04-03 AU AU41919/00A patent/AU774054B2/en not_active Ceased
- 2000-04-03 EA EA200101017A patent/EA200101017A1/en unknown
- 2000-04-03 MX MXPA01009915A patent/MXPA01009915A/en unknown
- 2000-04-03 HU HU0201904A patent/HUP0201904A3/en unknown
- 2000-04-03 CA CA002369005A patent/CA2369005A1/en not_active Abandoned
- 2000-04-03 NZ NZ515238A patent/NZ515238A/en unknown
- 2000-04-03 CN CNA2005100794026A patent/CN1721401A/en active Pending
- 2000-04-03 BR BR0009421-8A patent/BR0009421A/en not_active Application Discontinuation
- 2000-04-03 EE EEP200100514A patent/EE200100514A/en unknown
- 2000-04-03 PL PL00351323A patent/PL351323A1/en not_active Application Discontinuation
- 2000-04-03 CN CN00807734A patent/CN1351588A/en active Pending
- 2000-04-03 EP EP00921626A patent/EP1165504A2/en not_active Withdrawn
- 2000-04-03 KR KR1020017012479A patent/KR20020003559A/en not_active Application Discontinuation
- 2000-04-03 WO PCT/US2000/008840 patent/WO2000059878A2/en not_active Application Discontinuation
- 2000-04-03 JP JP2000609391A patent/JP2002541141A/en active Pending
- 2000-04-03 IL IL14552800A patent/IL145528A0/en unknown
- 2000-04-03 CZ CZ20013524A patent/CZ20013524A3/en unknown
- 2000-04-03 SK SK1402-2001A patent/SK14022001A3/en unknown
-
2001
- 2001-09-28 IS IS6096A patent/IS6096A/en unknown
- 2001-10-01 NO NO20014768A patent/NO20014768L/en not_active Application Discontinuation
- 2001-10-16 BG BG106019A patent/BG106019A/en unknown
- 2001-10-23 HR HR20010777A patent/HRP20010777A2/en not_active Application Discontinuation
-
2004
- 2004-08-24 AU AU2004205210A patent/AU2004205210A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2004205210A1 (en) | 2004-09-23 |
EE200100514A (en) | 2002-12-16 |
WO2000059878A2 (en) | 2000-10-12 |
CN1351588A (en) | 2002-05-29 |
BR0009421A (en) | 2002-03-26 |
HUP0201904A2 (en) | 2002-09-28 |
AU774054B2 (en) | 2004-06-17 |
KR20020003559A (en) | 2002-01-12 |
AU4191900A (en) | 2000-10-23 |
JP2002541141A (en) | 2002-12-03 |
NO20014768D0 (en) | 2001-10-01 |
MXPA01009915A (en) | 2003-08-20 |
CN1721401A (en) | 2006-01-18 |
CA2369005A1 (en) | 2000-10-12 |
EP1165504A2 (en) | 2002-01-02 |
HUP0201904A3 (en) | 2003-04-28 |
NZ515238A (en) | 2005-02-25 |
BG106019A (en) | 2002-06-28 |
SK14022001A3 (en) | 2002-03-05 |
IS6096A (en) | 2001-09-28 |
NO20014768L (en) | 2001-11-29 |
WO2000059878A3 (en) | 2001-08-09 |
HRP20010777A2 (en) | 2002-12-31 |
CZ20013524A3 (en) | 2002-06-12 |
IL145528A0 (en) | 2002-06-30 |
EA200101017A1 (en) | 2002-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL351323A1 (en) | Inhibitors of lfa−1 binding to icams and uses thereof | |
IL178864A0 (en) | 3'-prodrugs of 2'-deoxy-??-l-nucleosides | |
TWI315989B (en) | Soy depigmenting and skin care compositions | |
IL137935A0 (en) | Use of crf antagonists and related compositions | |
IL190220A0 (en) | Novel composition and use | |
EP1005330A4 (en) | Methods and compositions for targeting compounds to muscle | |
EP1227821A4 (en) | Therapeutic compositions and methods of use thereof | |
HK1055897A1 (en) | Antimicrobial compositions and methods of use | |
HK1048247A1 (en) | Stable carotene-xanthophyll beadlet compositions and methods of use | |
PL347691A1 (en) | Stable amorphous amifostine compositions and methods for the preparation and use of same | |
PT977812E (en) | Asphalt compositions and methods of preparation thereof | |
IL121269A0 (en) | Compositions and methods for reversibly increasing permeability of biomembranes | |
GB9922135D0 (en) | Compositions and uses | |
HK1033128A1 (en) | Benzo[c]quinolzine derivatives and their use as 5 alpha-reductases inhibitors | |
GB9927927D0 (en) | Compound composition and use | |
AU3863900A (en) | Prolyl peptidases and methods of use | |
HU9800623D0 (en) | Oral application of "(+)-o-demethyl-tramadol as analgesic active component | |
HUP0201610A2 (en) | Derivatives of 4'-demycarosyl-8a-aza-8a-homotylosin | |
EP1257650A4 (en) | Polymerase compositions and methods of use thereof | |
GB0010809D0 (en) | 'Thickener and binder | |
AU2007234506A1 (en) | Inhibitors of memapsin 2 and use thereof | |
PL351589A1 (en) | Use of n-substituted heterocyclylalkylamines as herbicides and novel n-substituted thienylalkylamines | |
EG24062A (en) | Novel composition and use | |
GB9905314D0 (en) | Therapy and use of compounds in therapy (2) | |
IL148187A0 (en) | Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |